Colon-specific delivery of curcumin by exploiting Eudragit-decorated chitosan nanoparticles in vitro and in vivo

Journal of Nanoparticle Research

Volumn 15, Issue 9, 2013, Pages

  Khatik, Renuka ^a   Mishra, Ramakant ^a   Verma, Ashwni ^a   Dwivedi, Pankaj ^a   Kumar, Vivek ^a   Gupta, Varsha ^a   Paliwal, Sarvesh Kumar ^b   Mishra, Prabhat Ranjan ^a   Dwivedi, Anil Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b BANASTHALI UNIVERSITY   (India)

Author keywords

Chitosan; Colon targeted drug delivery; Curcumin; Eudragit S 100; Nanoparticles

Indexed keywords

CHITOSAN; COATINGS; CONTROLLED DRUG DELIVERY; GELATION; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MORPHOLOGY; NANOPARTICLES; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SURFACE MORPHOLOGY;

CHITOSAN NANOPARTICLES; COLON-SPECIFIC DELIVERY; CURCUMIN; EQUIVALENT CONCENTRATIONS; EUDRAGIT S 100; IONIC GELATION METHOD; SOLVENT EVAPORATION METHOD; UPPER GASTROINTESTINAL;

TARGETED DRUG DELIVERY;

CHITOSAN; CURCUMIN; EUDRAGIT; NANOCARRIER; NANOCOATING; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON CANCER; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84882743582     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1893-x     Document Type: Article

References (47)

1. Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30(2):85-94
2. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363-398 (Pubitemid 36361976)
3. Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1-75
4. Araujo CC, Leon LL (2001) Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 96(5):723-728
5. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, Motterlini R (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371(Pt 3):887-895 (Pubitemid 36578887)
6. Bar-Sela G, Epelbaum R, Schaffer M (2010) Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem 17(3):190-197
7. Bhumkar DR, Pokharkar VB (2006) Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. Aaps Pharmscitech 7(2): E50
8. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ (1997) Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 14(10):1431-1436 (Pubitemid 27481075)
9. Cao N, Feng SS (2008) Doxorubicin conjugated to D-alphatocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 29(28):3856-3865
10. Cetin M, Atila A, Kadioglu Y (2010) Formulation and in vitro characterization of Eudragit(R) L100 and Eudragit (R) L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech 11(3):1250-1256
11. Dong Y, Feng SS (2004) Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25(14):2843-2849 (Pubitemid 38201309)
12. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M (2005) Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223(2):181-190 (Pubitemid 40719616)
13. Dwivedi P, Kansal S, Sharma M, Shukla R, Verma A, Shukla P, Tripathi P, Gupta P, Saini D, Khandelwal K, Verma R, Dwivedi AK, Mishra PR (2012) Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo. J Drug Target 20(10):883-896
14. Fryer RA, Galustian C, Dalgleish AG (2009) Recent advances and developments in treatment strategies against pancreatic cancer. Curr Clin Pharmacol 4(2):102-112
15. He M, Zhao Z, Yin L, Tang C, Yin C (2009) Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anti-cancer drug carriers. Int J Pharm 373(1-2):165-173
16. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95(8):4607-4612 (Pubitemid 28207960)
17. Hu Y, Ding Y, Ding D, Sun M, Zhang L, Jiang X, Yang C (2007) Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers. Biomacromolecules 8(4):1069-1076 (Pubitemid 46672682)
18. Jain S, Sahanoon OK, Blanton E, Schmitz A, Wannemuehler KA, Hoekstra RM, Quick RE (2010) Sodium dichloroisocyanurate tablets for routine treatment of household drinking water in periurban Ghana: a randomized controlled trial. Am J Trop Med Hyg 82(1):16-22
19. Jayakumar R, Reis RL, Mano JF (2007) Synthesis and characterization of pH-sensitive thiol-containing chitosan beads for controlled drug delivery applications. Drug Deliv 14(1):9-17 (Pubitemid 44764454)
20. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics. CA Cancer J Clin 56(2):106-130
21. Kansal S, Tandon R, Dwivedi P, Misra P, Verma PR, Dube A, Mishra PR (2012) Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. J Antimicrob Chemother 67(11):2650-2660
22. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59(3):597-601 (Pubitemid 29076056)
23. Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS (2002) In vitro drug release studies on guar gumbased colon-targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci 16(3):185-192 (Pubitemid 34786453)
24. Lee S-H, Baek H-H, Kim J, Choi S-W (2009) Core-shell poly(D,L-lactide-co- glycolide)/poly(ethyl 2-cyanoacrylate) microparticles with doxorubicin to reduce initial burst release. Macromol Res 17(12):1010-1014
25. Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y (1995) Inhibition of human immunodeficiency virus type-1 integrase by curcumin. BiochemPharmacol 49(8):1165-1170
26. Mulik R, Mahadik K, Paradkar A (2009) Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: physicochemical characterization and stability study. Eur J Pharm Sci 37(3-4):395-404
27. Muto T, Oya M (2003) Recent advances in diagnosis and treatment of colorectal T1 carcinoma. Dis Colon Rectum 46(10 Suppl):S89-S93 (Pubitemid 37266364)
28. Oosegi T, Onishi H, Machida Y (2008) Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system. Eur J Pharm Biopharm 68(2):260-266
29. Pan ChJ, Tang JJ, Weng YJ, Wang J, Huang N (2006) Preparation, characterization and anticoagulation of curcumineluting controlled biodegradable coating stents. J Control Release 116(1):42-49 (Pubitemid 44792298)
30. Peeyush KT, Gireesh G, Jobin M, Paulose CS (2009) Neuroprotective role of curcumin in the cerebellum of streptozotocin-induced diabetic rats. Life Sci 85(19-20):704-710
31. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE, Lubet RA (1996) Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17(6):1305-1311
32. Prabha S, Zhou WZ, Panyam J, Labhasetwar V (2002) Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm 244(1-2):105-115 (Pubitemid 35245451)
33. Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M (2008) Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76(11):1340-1351
34. Ritschel WA, Kearns GL (1999) Biopharmaceutical data of gastrointestinal tract. Handbook of basic pharmacokinetics including clinical applications, 7th edn, American pharmacists Association, Washington DC
35. Rodriguez M, Vila-Jato JL, Torres D (1998) Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release 55(1):67-77 (Pubitemid 28477565)
36. Sahoo SK, Ma W, Labhasetwar V (2004) Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer 112(2):335-340 (Pubitemid 39244375)
37. Sakuma S, Yano T, Masaoka Y, Kataoka M, Hiwatari K, Tachikawa H, Shoji Y, Kimura R, Ma H, Yang Z, Tang L, Hoffman RM, Yamashita S (2009) In vitro/in vivo biorecognition of lectin-immobilized fluorescent nanospheres for human colorectal cancer cells. J Control Release 134(1):2-10
38. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37(3-4):223-230
39. Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so far. Eur J Cancer 41(13):1955-1968 (Pubitemid 41557681)
40. Sharma M, Malik R, Verma A, Dwivedi P, Banoth GS, Pandey N, Sarkar J, Mishra PR, Dwivedi AK (2013) Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer. J Biomed Nanotechnol 9(1):96-106
41. Singodia D, Verma A, Khare P, Dube A, Mitra K, Mishra PR (2012) Investigations on feasibility of in situ development of amphotericin B liposomes for industrial applications. J Liposome Res 22(1):8-17
42. Sinha VR, Mittal BR, Bhutani KK, Kumria R (2004) Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm 269(1):101-108 (Pubitemid 38032827)
43. Tao L, Li K, Pereira MA (1997) Chemopreventive agentsinduced regression of azoxymethane-induced aberrant crypt foci with the recovery of hexosaminidase activity. Carcinogenesis 18(7):1415-1418 (Pubitemid 28134719)
44. Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki T, Yamamoto A, Muranishi S (1997) Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J Pharm Sci 86(9):1016-1021 (Pubitemid 27382903)
45. Tsai YM, Chien CF, Lin LC, Tsai TH (2011) Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm 416(1):331-338
46. Vidyalakshmi K, Rashmi KN, Kumar TMP, Siddaramaiah (2004) Studies on formulation and in vitro evaluation of PVA/chitosan blend films for drug delivery. J Macromol Sci Pure A41(10):1115-1122
47. Yoo JW, Giri N, Lee CH (2011) pH-sensitive Eudragit nanoparticles for mucosal drug delivery. Int J Pharm 403(1-2):262-267